Letrozole Tablets 2.5 Mg

Letrozole Tablets 2.5 Mg

Letrozole Tablets 2.5 Mg is a widely prescribed aromatase inhibitor used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It works by significantly lowering estrogen levels in the body, thereby slowing or stopping the growth of estrogen-dependent cancer cells. In hormonal therapy planning, alternative options such as Anastrazole Tablets 1 Mg – Generic Arimidex may also be considered based on patient tolerance and response, while higher-dose formulations like Letrozole Tablets 5 Mg are sometimes evaluated in specific clinical scenarios under oncologist supervision.

Mechanism of Action

Aromatase Enzyme Inhibition

Letrozole Tablets 2.5 Mg works by inhibiting the aromatase enzyme, which converts androgens into estrogen. This leads to a marked reduction in circulating estrogen levels.

Hormone-Dependent Cancer Control

By lowering estrogen levels, the medication limits the growth stimulation of hormone-sensitive breast cancer cells. For detailed clinical insights, refer to National Cancer Institute (NCI) and for safety information, consult Mayo Clinic – Letrozole Drug Information.

Approved Medical Uses

Breast Cancer Treatment

Letrozole Tablets 2.5 Mg is primarily used in postmenopausal women with estrogen receptor-positive breast cancer.

Adjuvant and Extended Therapy

It is also used as long-term hormonal therapy to reduce the risk of cancer recurrence after initial treatment such as surgery or chemotherapy.

Dosage and Administration

Letrozole Tablets 2.5 Mg is typically taken once daily, with or without food, as prescribed by a healthcare professional. Treatment duration may extend over several years depending on the patient’s condition. In clinical practice, Anastrazole Tablets 1 Mg – Generic Arimidex may be used as an alternative aromatase inhibitor, while dose adjustments or variations such as Letrozole Tablets 5 Mg can be considered in specific treatment protocols based on medical evaluation.

Clinical Effectiveness

Clinical studies have shown that Letrozole Tablets 2.5 Mg effectively reduces the risk of breast cancer recurrence and improves disease-free survival rates in postmenopausal women. It is considered a cornerstone therapy in hormone-sensitive breast cancer management.

Safety and Side Effects

Common Side Effects

• Hot flashes
• Joint pain
• Fatigue
• Headache
• Increased sweating

Serious Risks

• Bone density loss (osteoporosis)
• Cardiovascular complications
• Elevated cholesterol levels

Regular monitoring of bone health and cardiovascular status is recommended. For more details, refer to Mayo Clinic – Letrozole Drug Information.

Contraindications and Precautions

Letrozole Tablets 2.5 Mg should not be used in:

• Premenopausal women
• Pregnant or breastfeeding women
• Patients with known hypersensitivity to the drug

Medical evaluation is necessary before initiating therapy.

Drug Interactions

Letrozole Tablets 2.5 Mg may interact with hormone therapies, certain liver enzyme-modifying drugs, and other anticancer medications. Patients should inform their healthcare provider about all medications they are taking. For research-based information, refer to National Cancer Institute (NCI).

FAQs